Symbols

CBUS

Cibus·NASDAQ

--(--)

CBUS fundamentals

CBUS Q4 2025 Earnings

Cibus (CBUS) released its earnings on Mar 17, 2026: revenue was 1.06M (YoY -12.79%), missed estimates; EPS was -0.59 (YoY +32.18%), missed estimates.

Revenue / YoY

1.06M

-12.79%

EPS / YoY

-0.59

+32.18%

Report date

Mar 17, 2026

CBUS Earnings Call Summary for Q4,2025

$200M+ Rice Royalty Potential: 7 partnerships across Americas and India drive long-term revenue growth.
EU Regulatory Breakthrough: 100M acres of new opportunity for gene-edited crops in Europe.
12-15 Month Gene Editing Timeline: Enables rapid integration into seed companies' breeding programs.
First Fragrance Payment: Sustainable ingredients program demonstrates commercial viability, targeting $20M-$40M annual royalties.
Financial Stability: $22.3M capital raise and $10M cost savings extend cash runway to late 2026.

Earnings

EPS

Revenue

Revenue & Expenses

CBUS has released its 2025 Q4 earnings report, with revenue of 1.06M, reflecting a YoY change of -12.79%, and net profit of -31.95M, showing a YoY change of -23.81%. The Sankey diagram below clearly presents CBUS's revenue sources and cost distribution.

Key Indicators

Cibus (CBUS) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Cibus (CBUS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Cibus (CBUS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Cibus (CBUS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown